Research graph
References from How Does the Mono-Triazole Derivative Modulate Aβ42 Aggregation and Disrupt a Protofibril Structure: Insights from Molecular Dynamics Simulations. Local targets link to admitted publications; unresolved targets remain external evidence.
Aggregation of disease–related peptides
10.1016/bs.pmbts.2019.12.002 · 2020 · External reference
Über Eine Eigenartige Erkrankung Der Hirnrinde
1907 · External reference
Unresolved reference
External reference
Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer’s disease
10.1016/j.trci.2019.11.007 · 2019 · External reference
Rates of age– and amyloid β–associated cortical atrophy in older adults with superior memory performance
10.1016/j.dadm.2019.05.005 · 2019 · External reference
Family history is associated with phenotype in dementia with lewy bodies
10.3233/jad-190825 · 2020 · External reference
2020 Alzheimer’s disease facts and figures
10.1002/alz.12068 · 2020 · External reference
Amyloid β–protein and beyond: the path forward in Alzheimer’s disease
10.1016/j.conb.2020.02.003 · 2020 · External reference
A critical appraisal of amyloid−β-targeting therapies for Alzheimer disease
10.1038/s41582-018-0116-6 · 2019 · External reference
The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization
10.1021/cr3000994 · 2012 · External reference
Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity
10.1016/s0076-6879(99)09015-1 · 1999 · External reference
Characterizing the structural and thermodynamic properties of Aβ42 and Aβ40
10.1016/j.bbrc.2019.01.124 · 2019 · External reference
Mechanisms of amyloid fibril formation by proteins
2010 · External reference
Fundamentals of cross–seeding of amyloid proteins: an introduction
10.1039/c9tb01871a · 2019 · External reference
Molecular simulation aspects of amyloid peptides at membrane interface
10.1016/j.bbamem.2018.02.004 · 2018 · External reference
Rational design of a cocktail of inhibitors against Aβ aggregation
10.1002/chem.201905621 · 2020 · External reference
Ginnalin a inhibits aggregation, reverses fibrillogenesis, and alleviates cytotoxicity of amyloid β(1–42)
10.1021/acschemneuro.9b00673 · 2020 · External reference
Impact of the astaxanthin, betanin and EGCG compounds on small oligomers of amyloid Aβ40 peptide
10.1021/acs.jcim.9b01074 · 2020 · External reference
Interactions between curcumin derivatives and amyloid−β fibrils: insights from molecular dynamics simulations
10.1021/acs.jcim.9b00561 · 2019 · External reference
Small molecules as therapeutic drugs for Alzheimer’s disease
10.1016/j.mcn.2019.03.001 · 2019 · External reference
10.1016/j.bioorg.2019.03.058
10.1016/j.bioorg.2019.03.058 · 2019 · External reference
Benzofuran and indole: promising scaffolds for drug development in Alzheimer’s disease
10.1002/cmdc.201800156 · 2018 · External reference
Inhibition of β–amyloid channels with a drug candidate wgx–50 revealed by molecular dynamics simulations
10.1021/acs.jcim.7b00452 · 2017 · External reference
Inhibition of protein aggregation and amyloid formation by small molecules
10.1016/j.sbi.2014.12.004 · 2015 · External reference
Small–molecule inhibitors/modulators of amyloid−β peptide aggregation and toxicity for the treatment of Alzheimer’s disease: a patent review (2010–2012)
10.1517/13543776.2013.772983 · 2013 · External reference
Molecular dynamics simulations reveal the mechanism of graphene oxide nanosheet inhibition of Aβ1–42 peptide aggregation
10.1039/c9cp01803d · 2019 · External reference
Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles
10.1039/c8nr04506b · 2018 · External reference
Destruction of amyloid fibrils by graphene through penetration and extraction of peptides
10.1039/c5nr01172h · 2015 · External reference
Molecular modeling approach to explore the role of cathepsin B from Hordeum vulgare in the degradation of Aβ peptides
10.1039/c5mb00718f · 2016 · External reference
An aminopeptidase from Streptomyces sp. KK565 degrades beta amyloid monomers, oligomers and fibrils
10.1016/j.febslet.2010.08.048 · 2010 · External reference
Peptide-based molecular strategies to interfere with protein misfolding, aggregation and cell degeneration
10.1002/anie.201906908 · 2020 · External reference
Peptides, peptidomimetics, and carbohydrate–peptide conjugates as amyloidogenic aggregation inhibitors for Alzheimer’s disease
10.1021/acschemneuro.8b00185 · 2018 · External reference
Peptides as potential therapeutics for Alzheimer’s disease
10.3390/molecules23020283 · 2018 · External reference
Rationally designed peptides and peptidomimetics as inhibitors of amyloid−β (Aβ) aggregation: potential therapeutics of Alzheimer’s disease
10.1021/acscombsci.6b00116 · 2017 · External reference
Nature–inspired design and evolution of anti–amyloid antibodies
10.1074/jbc.ra118.004731 · 2019 · External reference
Structure–based design of conformation–and sequence–specific antibodies against amyloid
10.1073/pnas.1111232108 · 2012 · External reference
Alzheimer’s disease drug development pipeline: 2019
10.1016/j.trci.2019.05.008 · 2019 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Multifunctional mono–triazole derivatives inhibit Aβ42 aggregation and Cu2+–mediated Aβ42 aggregation and protect against Aβ42–induced cytotoxicity
10.1021/acs.chemrestox.9b00168 · 2019 · External reference
Physical and structural basis for polymorphism in amyloid fibrils
10.1002/pro.2544 · 2014 · External reference
Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures
10.1073/pnas.0905007106 · 2009 · External reference
Studies on the in vitro assembly of Aβ 1–40: implications for the search for Aβ fibril formation inhibitors
10.1006/jsbi.2000.4259 · 2000 · External reference
Direct visualisation of the β–sheet structure of synthetic Alzheimer’s amyloid
10.1006/jmbi.2000.3650 · 2000 · External reference
A new structural model of Alzheimer’s Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling
10.1016/j.jsb.2016.01.013 · 2016 · External reference
Fibrils with parallel in–register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy
10.1017/s0033583508004733 · 2008 · External reference
Implications of peptide assemblies in amyloid diseases
10.1039/c7cs00372b · 2017 · External reference
Monomeric Aβ1–40 and Aβ1–42 peptides in solution adopt very similar ramachandran map distributions that closely resemble random coil
10.1021/acs.biochem.5b01259 · 2016 · External reference
Dynamics of amyloid β fibrils revealed by solid–state NMR
10.1074/jbc.m111.308619 · 2012 · External reference
Atomic structures of amyloid cross–beta spines reveal varied steric zippers
10.1038/nature05695 · 2007 · External reference
Common core structure of amyloid fibrils by synchrotron X–ray diffraction
10.1006/jmbi.1997.1348 · 1997 · External reference
X–ray diffraction studies on amyloid filaments
10.1177/16.11.673 · 1968 · External reference
Solution structure of the Alzheimer amyloid β-peptide (1–42) in an apolar microenvironment
10.1046/j.1432-1033.2002.03271.x · 2002 · External reference
9–Methylfascaplysin is a more potent Aβ aggregation inhibitor than the marine–derived alkaloid, fascaplysin, and produces nanomolar neuroprotective effects in SH–SY5Y cells
10.3390/md17020121 · 2019 · External reference
Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ42 aggregation and protofibril destabilization: a molecular dynamics simulation study
10.1080/07391102.2018.1511475 · 2018 · External reference
Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid−β42 monomer: insights from molecular dynamics simulations
10.1080/07391102.2017.1291363 · 2017 · External reference
Tyrosine rotamer states in beta amyloid: signatures of aggregation and fibrillation
10.1021/acsomega.8b02408 · 2018 · External reference
Insights into the inhibitory mechanism of dicyanovinyl–substituted J147 derivative against Aβ42 Aggregation and protofibril destabilization: a molecular dynamics simulation study
10.1002/slct.201601970 · 2017 · External reference
Heme prevents amyloid beta peptide aggregation through hydrophobic interaction based on molecular dynamics simulation
10.1039/c3cp52354c · 2013 · External reference
3D structure of Alzheimer’s amyloid−β(1–42) fibrils
10.1073/pnas.0506723102 · 2005 · External reference
Interactions of a multifunctional di–triazole derivative with Alzheimer’s Aβ42 monomer and Aβ42 protofibril: a systematic molecular dynamics study
10.1039/c9cp04775a · 2020 · External reference
Molecular insights into destabilization of Alzheimer’s Aβ protofibril by arginine containing short peptides: a molecular modeling approach
10.1021/acsomega.8b02672 · 2019 · External reference
Adsorption mechanism of amyloid fibrils to graphene nanosheets and their structural destruction
10.1021/acs.jpcc.8b09893 · 2019 · External reference
Computational design and evaluation of β–sheet breaker peptides for destabilizing Alzheimer’s amyloid−β42 protofibrils
10.1002/jcb.29061 · 2019 · External reference
10.1007/978–94–024–1045–7
10.1007/978–94–024–1045–7 · 2017 · External reference
Molecular insights into Aβ42 protofibril destabilization with a fluorinated compound D744: a molecular dynamics simulation study
10.1002/jmr.2656 · 2017 · External reference
Identification of binding modes for amino naphthalene 2–cyanoacrylate (ANCA) probes to amyloid fibrils from molecular dynamics simulations
10.1021/acs.jpcb.6b10460 · 2017 · External reference
Investigation of the binding profiles of AZD2184 and ThioflavinT with amyloid−β (1–42) fibril by molecular docking and molecular dynamics methods
10.1021/acs.jpcb.5b05964 · 2015 · External reference
Computational insight into the binding profile of the second–generation PET tracer PI2620 with tau fibrils
10.1021/acschemneuro.9b00578 · 2020 · External reference
Novel disassembly mechanisms of sigmoid Aβ42 protofibrils by introduced neutral and charged drug molecules
10.1021/acschemneuro.9b00550 · 2020 · External reference
Revealing the mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin against hIAPP aggregation via computational simulations
10.1007/s12539-019-00352-9 · 2020 · External reference
Evaluation and validation of synergistic effects of amyloid beta inhibitor–goldnanoparticles complex on Alzheimer’s disease using deep neural network approach
10.1557/jmr.2018.452 · 2019 · External reference
GROMACS: High performance molecular simulations through multi–level parallelism from laptops to supercomputers
10.1016/j.softx.2015.06.001 · 2015 · External reference
Development and testing of the OPLS all–atom force field on conformational energetics and properties of organic liquids
10.1021/ja9621760 · 1996 · External reference
Evaluation and reparametrization of the OPLS–AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
10.1021/jp003919d · 2001 · External reference
Properties of monomeric Aβ42 probed by different sampling methods and force fields: Role of energy components
10.1063/1.5093184 · 2019 · External reference
Aβ monomers transiently sample oligomer and fibril–like configurations: ensemble characterization using a combined MD/NMR approach
10.1016/j.jmb.2013.06.021 · 2013 · External reference
Effects of all–atom force fields on amyloid oligomerization: replica exchange molecular dynamics simulations of the Aβ16–22 dimer and trimer
10.1039/c1cp20323a · 2011 · External reference
Treatment of halogen bonding in the OPLS-AA force field; application to potent anti-HIV agents
10.1021/ct300180w · 2012 · External reference
Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function
10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b · 1998 · External reference
Cell size effects in the molecular dynamics of the intrinsically disordered Aβ peptide
10.1063/1.5115085 · 2019 · External reference
Binding of 12–Crown–4 with Alzheimer’s Aβ40 and Aβ42 monomers and its effect on their conformation: insight from molecular dynamics simulations
10.1021/acs.molpharmaceut.7b00966 · 2018 · External reference
Inhibition mechanisms of a pyridazine–based amyloid inhibitor: as a β–sheet destabilizer and a helix bridge maker
10.1021/acs.jpcb.7b05189 · 2017 · External reference
Ring–like N–fold models of Aβ42 fibrils
10.1038/s41598-017-06846-0 · 2017 · External reference
Interaction models for water in relation to protein hydration
10.1007/978-94-015-7658-1_21 · 1981 · External reference
Effect of familial mutations on the interconversion of α–helix to β–sheet structures in an amyloid–forming peptide: insight from umbrella sampling simulations
10.1021/acschemneuro.8b00425 · 2019 · External reference
Compound CID 9998128 is a potential multitarget drug for Alzheimer’s disease
10.1021/acschemneuro.8b00091 · 2018 · External reference
Destabilization of Alzheimer’s Aβ42 protofibrils with a novel drug candidate wgx–50 by molecular dynamics simulations
10.1021/acs.jpcb.5b03116 · 2015 · External reference
A smooth particle mesh Ewald method
10.1063/1.470117 · 1995 · External reference
Particle mesh Ewald: An N.log(N) method for Ewald sums in large systems
10.1063/1.464397 · 1993 · External reference
LINCS: A linear constraint solver for molecular simulations
10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h · 1997 · External reference
Canonical sampling through velocity rescaling
10.1063/1.2408420 · 2007 · External reference
Molecular dynamics with coupling to an external bath
10.1063/1.448118 · 1984 · External reference
Polymorphic transitions in single crystals: A new molecular dynamics method
10.1063/1.328693 · 1981 · External reference
VMD: Visual molecular dynamics
10.1016/0263-7855(96)00018-5 · 1996 · External reference
Unresolved reference
2002 · External reference
Dictionary of protein secondary structure: pattern recognition of hydrogen–bonded and geometrical features
10.1002/bip.360221211 · 1983 · External reference
Peptide folding: when simulation meets experiment
10.1002/(sici)1521-3773(19990115)38:1/2<236::aid-anie236>3.0.co;2-m · 1999 · External reference
The MM/PBSA and MM/GBSA methods to estimate ligand–binding affinities
10.1517/17460441.2015.1032936 · 2015 · External reference
g_mmpbsa– a GROMACS tool for high–throughput MM–PBSA calculations
10.1021/ci500020m · 2014 · External reference
Molecular mechanism of the inhibition of EGCG on the Alzheimer Aβ1-42 dimer
10.1021/jp312573y · 2013 · External reference
Are current molecular dynamics force fields too helical?
10.1529/biophysj.108.132696 · 2008 · External reference
SHIFTX2: significantly improved protein chemical shift prediction
10.1007/s10858-011-9478-4 · 2011 · External reference
Criterion for orbital hybridization and charge distribution in chemical bonds
10.1073/pnas.45.8.1269 · 1959 · External reference
Contact electron–spin coupling of nuclear magnetic moments
10.1063/1.1729860 · 1959 · External reference
Solution NMR studies of the Aβ(1–40) and Aβ(1–42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation
10.1021/ja036813f · 2004 · External reference
Homogeneous and heterogeneous tertiary structure ensembles of amyloid–β peptides
10.1021/bi200732x · 2011 · External reference
Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis
10.1006/jmbi.2001.4970 · 2001 · External reference
A key role for lysine residues in amyloid β-protein folding, assembly, and toxicity
10.1021/cn3000247 · 2012 · External reference
Structure–based peptide design to modulate amyloid beta aggregation and reduce cytotoxicity
10.1371/journal.pone.0129087 · 2015 · External reference
Molecular structural basis for polymorphism in Alzheimer’s β–amyloid fibrils
10.1073/pnas.0806270105 · 2008 · External reference
Structural heterogeneity in familial Alzheimer’s disease mutants of amyloid–beta peptides
10.1039/c2mb25457c · 2013 · External reference
NMR–based site–resolved profiling of β–amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril
10.1074/jbc.ra119.008522 · 2020 · External reference
Mechanisms of amyloid formation revealed by solution NMR
10.1016/j.pnmrs.2015.05.002 · 2015 · External reference
Computational studies of protein aggregation: methods and applications
10.1146/annurev-physchem-040513-103738 · 2015 · External reference
Toxic species in amyloid disorders: oligomers or mature fibrils
10.4103/0972-2327.144284 · 2015 · External reference
Fibril elongation by Aβ17–42: kinetic network analysis of hybrid-resolution molecular dynamics simulations
10.1021/ja507002p · 2014 · External reference
Structural and fluctuational difference between two ends of Aβ amyloid fibril: MD simulations predict only one end has open conformations
10.1038/srep38422 · 2016 · External reference
Dihydrochalcone molecules destabilize Alzheimer’s amyloid-β protofibrils through binding to the protofibril cavity
10.1039/c8cp01631c · 2018 · External reference
12-Crown-4 ether disrupts the patient brain-derived amyloid-β-fibril trimer: Insight from all-atom molecular dynamics simulations
10.1021/acschemneuro.6b00185 · 2016 · External reference
Curcumin binds to Aβ1–40 peptides and fibrils stronger than ibuprofen and naproxen
10.1021/jp302506a · 2012 · External reference
